MODEL: SYRINGE DRIVER KL602
SPECIFICATIONS:
Syringe Size: 10, 20, 30, 50/60 ml
Applicable Syringe: Compatible with syringe of any standard
VTBI : 1-1000 ml ( ) in 0.1, 1, 10 ml increments
Flow Rate : Syringe 5 ml: 0.1-100 ml/h ( )
Syringe 10 ml: 0.1-300 ml/h
Syringe 20 ml: 0.1-600 ml/h
Syringe 30 ml: 0.1-800 ml/h
Syringe 50/60 ml: 0.1-1200 ml/h
Bolus Rate: 5 ml: 0.1-100 ml/h (in 0.01, 0.1, 1, 10 ml/h increments)
10 ml: 0.1-300 ml/h
20 ml: 0.1-600 ml/h
30 ml: 0.1-800 ml/h
50/60 ml: 0.1-1200 ml/h
Anti-Bolus: Automatic
Accuracy: ±2% (mechanical accuracy ≤1%)
Infusion Mode : Flow rate: ml/min, ml/h – Time-based – Body weight: mg/kg/min, mg/kg/h, ug/kg/min, ug/kg/h, etc.
KVO Rate : 0.1-1 ml/h (in 0.1 ml/h increments)
Alarms :Occlusion, near empty, end program, low battery, end battery, AC power off, motor malfunction, system malfunction, reminder alarm, pressure sensor error, syringe installation error, syringe drop off
Additional Features: Real-time infused volume, automatic power switching, automatic syringe identification, mute button, purge, bolus, anti-bolus, system memory, history log ( 50 000) , key locker
Drug library: Available
Occlusion Sensitivity : High, medium, low
Power Supply, AC: 110/230 V (optional), 50/60 Hz, 20 VA
Battery : 14.8 V, rechargeable
Battery Life ; 8 hours at 5 ml/h
Working Temperature : 5-40℃
Relative Humidity: ; 20-90%
Atmospheric Pressure: 860-1060 hpa
Size x Weight : 314x167x140 mm x 2.5kg
Safety Classification: Class Ⅱ, type CF

Fetal Doppler BF600+, 2Mhz portable with up 4hrs Battery operation
Wheelchair Manual Basic ,Fixed Armrest and Footrest (Steel-Nylon)
Patient Monitor 8.4’ inch Contec with ETCO2 & IBp: NiBp/SpO2/Temp/ECG
Hospital Bed 1-Function complete with mattress, IV Pole Side rails, ABS boards
Simulator IV Training arm
Walking frame Foldable Front Wheels size Large (ROLLATOR Foldable)
Obstetric Bed(Delivery) Manual Adjustments via double rachet
Biotain 0.5% chlorhexidine and 70% alcohol, 1L
Hypodermic Syringe luer Lock 1ml,box 100’s 
















Reviews
There are no reviews yet.